Antiviral drug resistance
Author(s)
Bibliographic Information
Antiviral drug resistance
Wiley, c1996
- : hbk. : alk. paper
Available at 8 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
-
Yukawa Institute for Theoretical Physics, Kyoto University基物研
: hbk. : alk. paperF4||ANT96062200
Note
Includes bibliographical references and index
Description and Table of Contents
Description
Considerable advances have been made in the treatment of viral diseases since the mid-1980s. This work discusses drugs introduced in the 1990s and provides clinical information gathered about existing drugs.
Table of Contents
- Antiviral Drug Resistance: Issues and Challenges
- Picornavirus: Capsid-Binding Agents
- Influenza A Viruses: Amanatadine and Rimantadine - Mechanisms
- Influenza A Viruses: Amanatadine and Rimantadine Resistance - Clinical Aspects
- Herpes Simplex Virus and Varicella Zoster Virus: Nucleosides and Foscarnet - Mechanisms
- Herpes Simplex Virus and Varicella Zoster Virus: Nucleosides and Foscarnet - Clinical Aspects
- Cytomegalovirus: Nucleosides and Foscarnet - Mechanisms
- Cytomegalovirus: Nucleosides and Foscarnet - Mechanisms
- Human Immunodeficiency Virus: Nucleosides and Foscarnet - Mechanisms
- Human Immunodeficiency Virus: Nucleosides and Foscarnet - Clinica Aspects
- Human Immunodeficiency Virus: Non-nucleoside Reverse Transcriptase Inhibitors - Mechanisms
- Human Immunodeficiency Virus: Non-nucleoside Reverse Transcriptase Inhibitors - Clinical
- Human Immunodeficiency Virus: Protease Inhibitors - Mechanisms and Clinical Aspects
- Human Immunodeficiency Virus: The Population Dynamics of HIV Disease Resistance.
by "Nielsen BookData"